Non-Viral Engineering of Primary Human Macrophages Using a cGMP-Compliant Electroporation Platform

被引：0
|
作者：
Strickland, Ashley B. [1 ]
Allen, Cornell [1 ]
Ciesliga, Camille [1 ]
Papademetriou, Jason [1 ]
Unsworth, Lauren E. [1 ]
Brady, James [1 ]
机构：
[1] MaxCyte Inc, Rockville, MD USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
288
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [1] EFFICIENT AND SCALABLE T CELL ENGINEERING FOR ADVANCING CANCER IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA BY A CGMP-COMPLIANT NON-VIRAL CELL ENGINEERING PLATFORM
    Chua, A.
    Gee, P.
    Ding, E.
    Brady, J.
    Koh, S.
    CYTOTHERAPY, 2021, 23 (05) : S95 - S95
  • [2] CGMP-COMPLIANT, CLINICAL SCALE, NON-VIRAL PLATFORM FOR EFFICIENT GENE EDITING USING CRISPR/CAS9
    Li, L.
    Natarajan, P.
    Allen, C.
    Peshwa, M. V.
    CYTOTHERAPY, 2014, 16 (04) : S37 - S37
  • [3] Non-Viral Cell Engineering of Peripheral Blood Natural Killer Cells Using a GMP-Compliant, Scalable Electroporation Platform
    Unsworth, Lauren E.
    Strickland, Ashley B.
    Allen, Cornell
    Brady, James
    MOLECULAR THERAPY, 2024, 32 (04) : 428 - 428
  • [4] Complex Engineering of Primary Human T Cells Using Non-Viral Intracellular Delivery with the Solupore Platform
    Dunne, Susan
    Martin, Darren
    Kavanagh, Heather
    Schwaber, Jessica
    O'Dea, Shirley
    MOLECULAR THERAPY, 2021, 29 (04) : 231 - 231
  • [5] Efficient non-viral DNA-mediated gene transfer to human primary myoblasts using electroporation
    Espinos, E
    Liu, JH
    Bader, CR
    Bernheim, L
    NEUROMUSCULAR DISORDERS, 2001, 11 (04) : 341 - 349
  • [6] Efficient Scalable Manufacturing of Virus-Like Particles for the Delivery of CRISPR-Cas9 Ribonucleoproteins Using a cGMP-Compliant Electroporation Platform
    Tien Nguyen
    Gee, Peter
    Menarguez, Sean
    Mancini, Andrew G.
    Romito, Marianna
    Strickland, Ashley B.
    Unsworth, Lauren E.
    Sumen, Cenk
    Papademetriou, Jason
    Daher, Isabel
    Brady, James
    MOLECULAR THERAPY, 2024, 32 (04) : 808 - 809
  • [7] CRISPR-mediated gene editing using a cGMP-compliant non-viral cell engineering: from iPSC disease modelling to clinically-meaningful correction of monogenic disease mutations in patient cells
    Carmen, J.
    Li, L.
    Allen, C.
    Viley, A.
    Natarajan, P.
    Shivakumar, R.
    Steger, K.
    Brady, J.
    HUMAN GENE THERAPY, 2018, 29 (12) : A116 - A116
  • [8] Generation of Human CAR-T Cells Using the Solupore Non-Viral Cell Engineering Platform
    Kavanagh, Heather
    Dunne, Susan
    McFadden, Emily
    O'Dea, Shirley
    MOLECULAR THERAPY, 2020, 28 (04) : 478 - 478
  • [9] Engineering Directed Tropism in the Non-Viral ARMMs Delivery Platform
    Piccinotti, Silvia
    Thomas, Mike
    Zhao, Wendy
    Valkov, Nelly
    Schupp, Patrick
    Wang, Qiyu
    Sun, Lucy
    Liu, Shu-Lin
    Baghbantaraghdari, Zahra
    Chang, Chou-Wei
    Zhou, Hongru
    Yu, Qin
    Nabhan, Joseph
    MOLECULAR THERAPY, 2024, 32 (04) : 594 - 595
  • [10] NON-VIRAL INTRACELLULAR DELIVERY TO ACHIEVE COMPLEX ENGINEERING OF PRIMARY HUMAN T CELLS USING SOLUPORE TECHNOLOGY
    Schwaber, J.
    Dunne, S.
    Martin, D.
    Kavanagh, H.
    O'Dea, S.
    CYTOTHERAPY, 2021, 23 (05) : S91 - S91
12345